- Report
- December 2018
- 14 Pages
Global
From €9102EUR$10,000USD£7,731GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 74 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- September 2023
- 74 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- August 2023
- 108 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 100 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
- Report
- October 2023
- 80 Pages
Russia
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Brazil
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Poland
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Japan
From €1365EUR$1,500USD£1,160GBP
- Report
- October 2023
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,160GBP
- Report
- May 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- December 2024
- 90 Pages
United States
From €1387EUR$1,524USD£1,178GBP
€1981EUR$2,177USD£1,683GBP
- Report
- November 2024
- 110 Pages
North America
From €1556EUR$1,710USD£1,322GBP
€2224EUR$2,443USD£1,889GBP
- Report
- November 2024
- 90 Pages
Australia
From €1184EUR$1,301USD£1,006GBP
€1692EUR$1,859USD£1,437GBP
- Report
- November 2024
- 150 Pages
United Kingdom
From €1269EUR$1,394USD£1,077GBP
€1812EUR$1,991USD£1,539GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more